We invite you to experience the Galaxy System™ at AABIP 2024 – Booth 19

Noah Medical is building the future of medical robotics, and the Galaxy System is Noah Medical’s first commercial robotic system. The company’s mission is to deliver adoptable clinical solutions through innovative endoluminal technologies to enhance the quality of life for patients globally.

Increasing Diagnostic Yield in Bronchoscopy is Hard, Galaxy can help.

Designed to keep the lesion in sight, the Galaxy System supports image-integrated targeting to achieve Tool-in-Lesion Confirmation and provide unparalleled diagnostic confidence helping you more accurately and precisely diagnose earlier stage lung cancer.

Visualize this: Procedures where Tool-in Lesion is always in sight

How important is it to you to leave the bronchoscopy suite confident you have the necessary biopsy tissue for an accurate diagnosis?

Target center strike: Looks can be deceiving

CT-to-body divergence is an issue, different vantage points tell different stories as you target the lesion. With the Galaxy System, having the lesion in sight can deliver the diagnostic confidence to strike the center of the lesion and avoid “watch and wait.”

Confirmed and confident: Let us help you increase your vision in lung cancer detection

Designed to keep the lesion always in sight, Galaxy builds a 3D image to enhance a clinician’s vision, and integrates imaging so you have confidence your tool was in the lesion.

Have a Galaxy System Experience at Booth 19. Register or click below to learn more.

• Register with AABIP for a learning session featuring Galaxy
  • *Lunch Symposium: Solving for Diagnostic Confidence: Real-time imaging and Tool-in-lesion confirmation *This session is not included in the main Conference CME/CPD credit
• Learn more about Galaxy at AABIP: visit https://www.noahmed.com/AABIP2024

Stay informed with live updates from AABIP 2024 on X (formerly Twitter) and Linkedin.

We look forward to meeting you.